Next Article in Journal
Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
Next Article in Special Issue
Severity of Fatigue and Its Relationship with TSH before and after Levothyroxine Replacement Therapy in Patients with Primary Hypothyroidism
Previous Article in Journal
Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia
Previous Article in Special Issue
Graves’ Eye Disease: Clinical and Radiological Diagnosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 11
Issue 2
10.3390/biomedicines11020381
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Optimization of Thyroid Volume Determination by Stitched 3D-Ultrasound Data Sets in Patients with Structural Thyroid Disease

by
Philipp Seifert
,
Sophie-Luise Ullrich
,
Christian Kühnel
,
Falk Gühne
,
Robert Drescher
,
Thomas Winkens
and
Martin Freesmeyer
*
Clinic of Nuclear Medicine, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany
*
Author to whom correspondence should be addressed.
Biomedicines 2023, 11(2), 381; https://doi.org/10.3390/biomedicines11020381
Submission received: 9 January 2023 / Revised: 23 January 2023 / Accepted: 26 January 2023 / Published: 27 January 2023
(This article belongs to the Special Issue Mechanisms and Novel Therapeutic Approaches for Thyroid Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
Ultrasound (US) is the most important imaging method for the assessment of structural disorders of the thyroid. A precise volume determination is relevant for therapy planning and outcome monitoring. However, the accuracy of 2D-US is limited, especially in cases of organ enlargements and deformations. Software-based “stitching” of separately acquired 3D-US data revealed precise volume determination in thyroid phantoms. The purpose of this study is to investigate the feasibility and accuracy of 3D-US stitching in patients with structural thyroid disease. A total of 31 patients from the clinical routine were involved, receiving conventional 2D-US (conUS), sensor-navigated 3D-US (3DsnUS), mechanically-swept 3D-US (3DmsUS), and I-124-PET/CT as reference standard. Regarding 3DsnUS and 3DmsUS, separately acquired 3D-US images (per thyroid lobe) were merged to one comprehensive data set. Subsequently, anatomical correctness of the stitching process was analysed via secondary image fusion with the I-124-PET images. Volumetric determinations were conducted by the ellipsoid model (EM) on conUS and CT, and manually drawn segmental contouring (MC) on 3DsnUS, 3DmsUS, CT, and I-124-PET/CT. Mean volume of the thyroid glands was 44.1 ± 25.8 mL (I-124-PET-MC = reference). Highly significant correlations (all p < 0.0001) were observed for conUS-EM (r = 0.892), 3DsnUS-MC (r = 0.988), 3DmsUS-MC (r = 0.978), CT-EM (0.956), and CT-MC (0.986), respectively. The mean volume differences (standard deviations, limits of agreement) in comparison with the reference were −10.50 mL (±11.56 mL, −33.62 to 12.24), −3.74 mL (±3.74 mL, −11.39 to 3.78), and 0.62 mL (±4.79 mL, −8.78 to 10.01) for conUS-EM, 3DsnUS-MC, and 3DmsUS-MC, respectively. Stitched 3D-US data sets of the thyroid enable accurate volumetric determination even in enlarged and deformed organs. The main limitation of high time expenditure may be overcome by artificial intelligence approaches.

1. Introduction

Depending on regional circumstances, structural deviations of the thyroid gland such as nodules and organ enlargements frequently occur. In areas of iodine deficiency, such as Germany, parenchymal disorders can be observed in >30% of the population [1,2]. Ultrasound (US) is the most important imaging method for the assessment of thyroid diseases, allowing for detailed morphological estimations as well as organ and lesion size measurements [3,4]. Its widespread availability, almost no side effects, high level of acceptance by both healthcare professionals and patients, excellent resolution and contrast in soft tissue, real-time applicability, portability, possibility of de facto unlimited follow-up scans, and very low procedural costs are well-known advantages of US examinations in general [5,6,7].
An accurate US-based determination of the thyroid volume is relevant for treatment planning, outcome assessment, and follow-up in the therapy of thyroid diseases. Precise volume measurements are especially important in the preparation of radioiodine therapies and minimal-invasive surgical approaches [8,9,10]. However, the diagnostic accuracy of conventional 2D-US (conUS) is limited by intraobserver and interobserver variability, a restricted field of view (FOV), and the invisibility of retrosternal or intrathoracic thyroid tissue [11,12,13].
Some of these limitations can be overcome by 3D-US applications, especially in view of volume determination [14]. The possibility of segmental contouring, in analogy to other sectional imaging methods such as CT or MRI, enables significant improvement of the diagnostic accuracy [15,16]. Furthermore, it is possible to export and archive acquired 3D-US data sets which allow for retrospective reviewing, post-processing, post-hoc volume analyses, and secondary fusion with other 3D imaging modalities [17]. Various technical methods of 3D-US data acquisition have been developed, including sensor-navigated (3DsnUS) and mechanically swept approaches (3DmsUS) [18].
However, 3D-US is limited to the FOV of the used US probe, restricting precise volume measurements especially in case of isthmus enlargement. One possible solution to overcome this limitation is the so-called “stitching” technique, in which two separately acquired 3D-US data sets per thyroid lobe are merged together. In previous phantom studies the feasibility and accuracy of this novel software-based method has been analysed. The results revealed extremely precise volume measurements of the investigated thyroid phantoms even in case of very large and deformed organs [19,20]. The aim of the present study was to translate the stitching technique into the clinic setting and to investigate its feasibility and accuracy for both 3DsnUS and 3DmsUS.

2. Materials and Methods

Subject of the study were 31 patients with structural thyroid disease recruited from the clinical routine of a university nuclear medicine between April 2015 and November 2016. When conventional thyroid diagnostics, consisting of history, clinical examination, laboratory parameters, sonography, and scintigraphy, revealed unclear findings, the patients received additional I-124-PET/CT and subsequent PET/US fusion imaging as part of several different clinical study protocols, published in 2019 and 2020 [21,22,23]. Therefore, PET/CT was conducted independently of the present study protocol. In a part of these patients, additional 3D-US investigations were performed. This represents the object of interest of this work.
All patients were informed in detail and signed a consent form. The 3D-US examination results had no influence on the treatment course of the respective thyroid diseases. Local ethics committee approved the scientific evaluation of the collected data (reg. no.: “2021-2376-Daten”).

2.1. Ultrasound Examinations

US was performed on the LOGIQ E9 device (GE Medical Systems, Milwaukee, WI, USA). Separate scans of each thyroid lobe (left and right) were acquired. ConUS was conducted with the linear matrix array ML6-15 according to a local standard operating procedure [7]. For 3DsnUS, a magnetic field and specific position sensors equipped to the ML6-15 probe were necessary. For 3DmsUS an automated mechanically swept 3D convex probe (RAB4-8) was used. The methodology of these 3D-US applications has been described in several previous publications [14,19,20]. All 3D-US data sets were transferred to the research software PMOD (Version 4.1, PMOD Technologies Ltd., Zürich, Switzerland). Examination settings and acquired data sets are depictured in Figure 1 and Figure 2.
The parameter settings for the two investigated 3D-US applications are shown in Table 1.

2.2. Stitching of 3D-US Data Sets

In both settings, 3DsnUS and 3DmsUS, separately acquired scans (one scan per thyroid lobe: left and right) were merged together (=stitching) in PMOD software by use of a specific stitching module. To stitch both data sets together, it was possible to move one previously defined thyroid lobe on each plane and manually align it according to the assumed anatomy. The tool allowed for translations in each of three axes (x, y, z) as well as rotations within each of the three planes (transverse, sagittal, and coronal). To provide a consistent basis for processing, the larger thyroid lobe was constantly defined as fixed and the smaller as movable. Suitable pivot point for rotary movements were set as centrally as possible in the respective isthmuses. Initial starting point for the stitching procedure was the transverse plane. Various anatomical landmarks were used for orientation. Beforehand, an overview of possible features or anomalies was carried out. Those should be located as close as possible to the isthmus in order to be mapped on both data sets. Parenchymal changes such as nodes or cysts close to the isthmus and calcifications of the trachea proved helpful. These were aligned and overlapped in all axes.
The finished stitched 3D-US data sets could then be transferred to the clinical software Syngo.via (version VB50B, Siemens, Erlangen, Germany). Herein, secondary fusion with the available I-124-PET scans was conducted, allowing a precise assessment of the anatomical correctness of the 3D-US stitching process. According to the findings, respective corrections were performed on PMOD software and again re-evaluated by I-124-PET fusion imaging on Syngo-via software (Figure 3).

2.3. Volumetric Determination

Two different methods were used to measure the thyroid volumes. ConUS data were evaluated via the ellipsoid model (conUS-EM): V = (4/3) * π * (largest cranial-caudal diameter/2) * (largest anterior-posterior diameter/2) * (orthograde medial-lateral diameter/2) [24]. Volume determination of the stitched 3D-US data sets were performed by multiple manually drawn segmental contouring applications (MC) in transverse plane in PMOD software according to the organ boarders (3DsnUS-MC, 3DmsUS-MC). The same method was also used to measure the thyroid volumes on I-124-PET/CT scans in Syngo.via software (PET/CT-MC), which defined the reference standard values. To avoid prejudiced biases, determination of the reference was performed only after the measurements of the thyroid volumes on the several US data sets. For further comparative analyses, the CT scans alone were additionally evaluated in Syngo.via software using both the MC and EM methods (CT-EM, CT-MC). ConUS-EM and CT-EM applications are demonstrated in Figure 4.
MC applications on 3D-US (3DsnUS-MC and 3DmsUS-MC), CT (CT-MC), and I-124-PET/CT (PET/CT-MC) are shown in Figure 5.

2.4. Statistics

Data were recorded in Excel software (version 16.59, Microsoft Corporation, Redmond, WA, USA). Statistical analysis was performed using SPSS software (version 28.0.1.0, IBM Corporation, Ehningen, Germany). Diagrams and charts were created in Excel. Figures were prepared in PowerPoint software (version 16.62, Microsoft Corporation, Redmond, WA, USA). Bland–Altman plots were created to assess the agreement of the several measured volumes with the reference standard. For the comparison of not normally distributed metric values, Mann–Whitney U test (MWU) was used. For correlation analyses, the Pearson correlation coefficient was applied (r). p < 0.05 was considered statistically significant.

3. Results

A total number (N) of 31 patients (12 men, 19 women, age: 57 ± 15 years) were included, 21 patients received 3DsnUS and 3DmsUS, 10 patients only received 3DsnUS but no 3DmsUS. Hence, a total of 52 3D-US examinations were carried out. In all cases, parenchymal changes were present in the form of thyroid nodules (multi-nodular goitre in 87.1%). Application of 3D-US, stitching of the separately acquired 3D-US data sets in PMOD software, and secondary image fusion of the stitched comprehensive 3D-US with the I-124-PET image in Syngo.via software was feasible in all cases. Two examples of patients with isthmus nodules are shown in Figure 6.
Cumulative results of all volume determination are displayed in Table 2.
All investigated methods revealed very strong correlations with the reference standard with superior values (not significant) for 3D-US. No significant differences between 3DsnUS-MC and 3DmsUS-MC were observed. A comparative graphical presentation, visualizing the broader spread of the conUS-EM versus 3D-US-MC measurements, is shown in Chart 1.
Additionally, the Bland–Altman plots demonstrate the wider deviations (in relation to the reference standard PET/CT-MC) of conUS-EM volume measurements in comparison to 3DsnUS-MC and 3DmsUS-MC (Chart 2). The mean (SD, LoA) of the measured volume differences were −10.50 mL (±11.56, −33.62 to 12.24), −3.74 mL (±3.74, −11.39 to 3.78), and 0.62 mL (±4.79, −8.78 to 10.01) for conUS-EM, 3DsnUS-MC, and 3DmsUS-MC, respectively.

4. Discussion

The present pilot study represents the first in vivo application of stitched 3D-US data sets for volume measurements of the thyroid gland in patients with structural thyroid disease. Stitching of two separately acquired 3D-US data sets has been investigated in two previous phantom studies [19,20]. The volumes determined by the reference standard (multiple manually drawn segmental contouring of I-124-PET/CT scans) revealed a patient cohort with enlarged organs (44.1 ± 25.8 mL).
The PET/CT scans were not performed for the purpose of this study but as part of other studies [21,22,23]. I-124-PET/CT-MC was considered a very accurate reference standard method due to the hybrid approach including functional (PET) and morphological (CT) information. CT alone has been described as a suitable 3D imaging reference for thyroid volume determination, but the limited soft tissue contrast can lead to inaccurate measurements [14,25,26]. I-124-PET alone, on the other hand, may include areas without iodine uptake (e.g., cysts, calcifications, or hypofunctioning lesion) and, therefore, might underestimate the actual thyroid volume. The combination of both methods has the potential to sufficiently compensate each other’s weaknesses.
Sensor-navigated 3D-US with the linear matrix array probe ML6-15 (3DsnUS) and mechanically swept 3D-US with the automated motor array 3D convex probe RAB4-8 (3DmsUS) were applicable in all cases. With 3DmsUS, only 21 of the 31 patients were examined due to organizational reasons. However, in a few cases the image quality was not optimal due to artefacts or incompletely captured pols and isthmuses (Figure 7), but still sufficient for diagnostic demands. No examinations needed to be excluded because of poor image quality.
In cases of 3DsnUS, the examiner had to pay attention to a constant probe movement speed in order to avoid artefacts. From the patient’s side, these could be reduced by a breath-holding technique. Motion artefacts made the stitching process and the application of the MC method more difficult and could lead to measurement inaccuracies. In theory, electromagnetic interferences from metal, mains, or LAN voltage fields are possible, but has not been observed in our examinations.
For accurate 3DmsUS results, constant orthograde fixation of the probe on the neck surface was necessary. An important prerequisite was the estimation of the correct probe position in order to be able to capture the entire thyroid lobe, restricted by a maximum angle of 84°. Incompletely captured lobes needed to be avoided. In nearly all cases repetitive attempts very necessary. The acquisition parameters for 3D-US were individually optimized and, therefore, examiner-dependent, resulting in variable image quality.
The larynx was found to be an influencing factor in the acquisition process of 3D-US in general. In order to capture the thyroid at any height, the probe had to be moved around the larynx, resulting in a tilt of the 3D data sets. This was a challenging factor for the stitching process (Figure 8).
Digital Imaging and Communications in Medicine (DICOM) data exports to external storage devices as well as transferal to and post-processing in the research software PMOD and the clinical software Syngo.via were successfully performed in analogy to several previous studies [17,19,20]. For 3DmsUS, edge length voxel corrections were necessary (equally to previous study protocols) [20].
For stitching procedures, trachea, calcifications in the cartilaginous braces, and isthmus-related parenchymal changes such as nodules or cysts were found to be helpful anatomical landmarks. The larger the overlapping portions of both thyroid lobes, the higher the probability of detection of common landmarks. However, correct anatomical stitching is challenging. In the present study, fusion with the I-124-PET scans enabled accurate results but was a time-consuming process. In addition, variable head positioning during US and PET acquisitions could lead to variations in thyroid presentation. Overall, the manual stitching method was successfully performed in all investigated patients, but a major disadvantage was the relatively high time-consumption of the entire process (Chart 3).
The methodological approach of US stitching has also been investigated in other disciplines, e.g., gynaecology, echocardiography, oncology, and ophthalmology [27,28,29,30]. A common goal is to optimize the image assessment with the help of an extended FOV, resulting in one comprehensive 3D-US data set of the area of interest (in this case the entire thyroid gland). Important advantages are the possibilities to export and archive the acquired 3D-US data sets, allowing for retrospective reviewing, post-processing, post-hoc volume analyses, and secondary fusion with other 3D modalities [17]. The stitched 3D-US data sets of the entire thyroid gland can theoretically be fused with any other 3D images, e.g., 99m-technetium-pertechnetate- or I-123-SPECT(/CT) data (Figure 9). In contrast to I-124-PET/CT (~6.5 mSv), 99m-technetium-pertechnetate- or I-123-SPECT scans can be performed immediately after the standard planar scintigraphy without additional radiation exposure [31]. This can be very helpful for the functional assessment of thyroid nodules in cases of unclear conventional diagnostic results. Previous studies addressed this aspect for 99m-technetium-pertechnetate SPECT/US and I-124-PET/US fusion imaging and demonstrated relevant diagnostic benefits. However, so far PET/US and SPECT/US fusion imaging have mainly been reported in the context of real-time applications, but not for a secondary fusion approach.
A major advantage of 3D-US of the thyroid gland is the ability to apply segmental organ contouring (the MC method). In contrast to EM, this approach allows for accurate volume determination, especially cases of enlarged and deformed thyroid glands such as those investigated in the present study. The results show very high correlation coefficients between 3DsnUS-MC and 3DmsUS-MC with the reference standard. In comparison to the volumes determined by conUS-EM, 3D-US revealed favourable results with relevantly lower dispersions, particularly for the larger thyroid glands. In analogy to other studies, an average underestimation of thyroid volume was observed for the conUS-EM method and relative differences were found in a range of 13–23%, which is consistent with the results of this study (mean: 24.1%) [25,32,33,34]. Analyses of the patients with the highest differences between conUS-EM and the gold standard (>40%; N = 7) in this study revealed two main reasons for the inaccurate conUS-EM results:
  • in large thyroid glands, the maximum cranial–caudal diameter could not be measured correctly on conUS because the respective organ pols were not covered within the limited FOV
  • substantial deviation of the organ shape from the estimated ellipsoid model due to nodules and cysts, especially in the isthmus.
Another measurement error may result from the correction factor of the EM. Various factors have been proposed and discussed in the literature [35]. Initially, 0.479 was suggested [24]. Other studies used π/6 (=0.524) [36]. In addition, several slightly higher or lower values have been tested [32,37]. In clinical practice, the rounded factor of 0.5 is commonly used. Therefore, we decided to use the widespread clinical standard value for comparative analyses in the present study.
Previous publications were predominantly concerned with 3DsnUS and without the stitching method. The present study is the first to report the use of two different 3D-US applications including stitching in patients with structural thyroid disease. A summary of the literature is given in Table 3.
Schlögl et al. (2001), Lyshchik et al. (2004), and Licht et al. (2014) examined in vivo thyroid glands in addition to phantoms [14,15,38]. The differences and standard deviations are similar to the results of the present study. The mean values are slightly lower than in the current results with respect to the 3DsnUS. Standard deviations are almost the same. However, the thyroid glands examined in the studies of Schlögl et al. (2001) and Lyshchik et al. (2004) had significantly lower volumes, and in Schlögl et al. (2001) data sets with poor image quality were excluded. In the present study, no data sets were excluded regardless of the presence of poor image quality or image artefacts. Additionally, 3DmsUS results from the above mentioned studies were also comparable, but the standard deviation was higher in the present study, which can be explained by the more complex organ structures and types.

Limitations

With regard to the study design, several limitations must be admitted that may have influenced the results and their interpretation:
  • The investigated patient group consisted of subjects who received further diagnostics due to unclear constellations of conventional diagnostics. Thus, the 3D-US data were collected from a complex pre-selected patient cohort that does not reflect the average population. In the present study, the focus was set to patients with structural thyroid diseases in order to investigate the value of the novel methodology with regard to this aspect.
  • Due to the small number of cases, the results have limited reliability statistically. Furthermore, the sample sizes of patients with 3DsnUS and 3DmsUS were different; only 21 of the 31 patients received 3DmsUS.
  • MC volume determinations were performed exclusively by one examiner. Accordingly, no statement regarding interobserver variability is possible. On the other hand, there was no bias due to different levels of experience.
  • Intraobserver variability was not investigated because each measurement was only carried out once. Given a total of 5.183 manually drawn contours (MC analyses), no effort was made to repeat the measurements.

5. Conclusions and Outlook

In this work, it was shown that the accuracy of volumetric determination of 3D-US data sets of the thyroid gland is superior to those of conventional 2D-US and comparable to those of other 3D sectional imaging methods such as CT. Additionally, 3D-US techniques combine the advantage of comparable precision with overcoming the disadvantage of radiation exposure of CT and the limited availability of MRI. Due to the multitude of benefits, ultrasound in general is one of the most important diagnostic imaging tools in clinical and ambulatory patient care. Nevertheless, limitations arise for the establishment of 3D-US procedures in clinical practice. These mainly relate to time expenditure and the limited availability of additional software still required for volumetric calculations.
Promising prospects are artificial intelligence (AI) approaches, which already exist in several fields of medicine, medical imaging, and ultrasound, in particular [42,43,44]. To overcome the limitations of high time-consumption and examiner-dependency of the MC method, AI-based automated segmentation methods have been evaluated [45,46]. Chen et al. summarized the various methods already developed for automated segmentation of the thyroid gland from 2D and 3D data sets in 2020 [25,32,33,34,47,48]. However, all methods so far focused exclusively on normal thyroid glands, publications addressing automated segmentation of pathological or atypically shaped thyroid glands are still pending. Furthermore, limitations currently arise from elaborate training processes and the need for extensive data input [49].

Author Contributions

Conceptualization, P.S., S.-L.U. and M.F.; methodology, P.S., S.-L.U., C.K. and M.F.; software, S.-L.U. and C.K.; validation, P.S., R.D., F.G. and M.F.; formal analysis, P.S. and S.-L.U.; investigation, P.S., T.W. and M.F.; resources, M.F.; data curation, P.S., S.-L.U. and C.K.; writing—original draft preparation, P.S. and S.-L.U.; writing—review and editing, F.G., R.D., T.W. and M.F.; visualization, P.S. and S.-L.U.; supervision, P.S. and M.F.; project administration, M.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Jena University Hospital (protocol code “2021-2376-Daten”, date of approval: 31-AUG-2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Due to ethical regulations, the data will not be made public.

Acknowledgments

We acknowledge support by the German Research Foundation Projekt-Nr. 512648189 and the Open Access Publication Fund of the Thueringer Universitaets- und Landesbibliothek Jena.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Reiners, C.; Wegscheider, K.; Schicha, H.; Theissen, P.; Vaupel, R.; Wrbitzky, R.; Schumm-Draeger, P.-M. Prevalence of thyroid disorders in the working population of Germany: Ultrasonography screening in 96,278 unselected employees. Thyroid 2004, 14, 926–932. [Google Scholar] [CrossRef]
  2. Verburg, F.A.; Grelle, I.; Tatschner, K.; Reiners, C.; Luster, M. Prevalence of thyroid disorders in elderly people in Germany. A screening study in a country with endemic goitre. Nuklearmedizin 2017, 56, 9–13. [Google Scholar] [CrossRef]
  3. Meltzer, C.J.; Irish, J.; Angelos, P.; Busaidy, N.L.; Davies, L.; Dwojak, S.; Ferris, R.L.; Haugen, B.R.; Harrell, R.M.; Haymart, M.R.; et al. American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules. Head Neck 2019, 41, 843–856. [Google Scholar] [CrossRef] [Green Version]
  4. Richman, D.M.; Frates, M.C. Ultrasound of the Normal Thyroid with Technical Pearls and Pitfalls. Radiol. Clin. N. Am. 2020, 58, 1033–1039. [Google Scholar] [CrossRef] [PubMed]
  5. Hegedüs, L. Thyroid ultrasound. Endocrinol. Metab. Clin. N. Am. 2001, 30, 339–360. [Google Scholar] [CrossRef] [PubMed]
  6. Curriculum for Fundamentals of Ultrasound in Clinical Practice. J. Ultrasound Med. 2019, 38, 1937–1950. [CrossRef] [Green Version]
  7. Seifert, P.; Maikowski, I.; Winkens, T.; Kühnel, C.; Gühne, F.; Drescher, R.; Freesmeyer, M. Ultrasound Cine Loop Standard Operating Procedure for Benign Thyroid Diseases—Evaluation of Non-Physician Application. Diagnostics 2021, 11, 67. [Google Scholar] [CrossRef]
  8. Luster, M.; Pfestroff, A.; Hänscheid, H.; Verburg, F.A. Radioiodine Therapy. Semin. Nucl. Med. 2017, 47, 126–134. [Google Scholar] [CrossRef] [Green Version]
  9. Jongekkasit, I.; Jitpratoom, P.; Sasanakietkul, T.; Anuwong, A. Transoral Endoscopic Thyroidectomy for Thyroid Cancer. Endocrinol. Metab. Clin. N. Am. 2019, 48, 165–180. [Google Scholar] [CrossRef] [PubMed]
  10. Miccoli, P.; Fregoli, L.; Rossi, L.; Papini, P.; Ambrosini, C.E.; Bakkar, S.; De Napoli, L.; Aghababyan, A.; Matteucci, V.; Materazzi, G. Minimally invasive video-assisted thyroidectomy (MIVAT). Gland. Surg. 2020, 9 (Suppl. 1), 1–5. [Google Scholar] [CrossRef]
  11. Shapiro, R.S. Panoramic ultrasound of the thyroid. Thyroid 2003, 13, 177–181. [Google Scholar] [CrossRef]
  12. Schlögl, S.; Andermann, P.; Luster, M.; Reiners, C.; Lassmann, M. A novel thyroid phantom for ultrasound volumetry: Determination of intraobserver and interobserver variability. Thyroid 2006, 16, 41–46. [Google Scholar] [CrossRef] [PubMed]
  13. Andermann, P.; Schlögl, S.; Mäder, U.; Luster, M.; Lassmann, M.; Reiners, C. Intra- and interobserver variability of thyroid volume measurements in healthy adults by 2D versus 3D ultrasound. Nuklearmedizin 2007, 46, 1–7. [Google Scholar]
  14. Licht, K.; Darr, A.; Opfermann, T.; Winkens, T.; Freesmeyer, M. 3D ultrasonography is as accurate as low-dose CT in thyroid volumetry. Nuklearmedizin 2014, 53, 99–104. [Google Scholar] [CrossRef] [PubMed]
  15. Lyshchik, A.; Drozd, V.; Reiners, C. Accuracy of three-dimensional ultrasound for thyroid volume measurement in children and adolescents. Thyroid 2004, 14, 113–120. [Google Scholar] [CrossRef]
  16. Freesmeyer, M.; Wiegand, S.; Schierz, J.-H.; Winkens, T.; Licht, K. Multimodal evaluation of 2-D and 3-D ultrasound, computed tomography and magnetic resonance imaging in measurements of the thyroid volume using universally applicable cross-sectional imaging software: A phantom study. Ultrasound Med. Biol. 2014, 40, 1453–1462. [Google Scholar] [CrossRef]
  17. Freesmeyer, M.; Darr, A.; Schierz, J.-H.; Schleußner, E.; Wiegand, S.; Opfermann, T. 3D ultrasound DICOM data of the thyroid gland. First experiences in exporting, archiving, second reading and 3D processing. Nuklearmedizin 2012, 51, 73–78. [Google Scholar] [CrossRef] [PubMed]
  18. Prager, R.W.; Ijaz, U.Z.; Gee, A.H.; Treece, G.M. Three-dimensional ultrasound imaging. Proc. Inst. Mech. Eng. Part H J. Eng. Med. 2010, 224, 193–223. [Google Scholar] [CrossRef]
  19. Freesmeyer, M.; Knichel, L.; Kuehnel, C.; Winkens, T. Stitching of sensor-navigated 3D ultrasound datasets for the determination of large thyroid volumes—A phantom study. Med. Ultrason. 2018, 20, 480–486. [Google Scholar] [CrossRef] [Green Version]
  20. Seifert, P.; Winkens, T.; Knichel, L.; Kühnel, C.; Freesmeyer, M. Stitching of 3D ultrasound datasets for the determination of large thyroid volumes—Phantom study part II: Mechanically-swept probes. Med. Ultrason. 2019, 21, 389–398. [Google Scholar] [CrossRef] [PubMed]
  21. Seifert, P.; Winkens, T.; Kühnel, C.; Gühne, F.; Freesmeyer, M. I-124-PET/US Fusion Imaging in Comparison to Conventional Diagnostics and Tc-99m Pertechnetate SPECT/US Fusion Imaging for the Function Assessment of Thyroid Nodules. Ultrasound Med. Biol. 2019, 45, 2298–2308. [Google Scholar] [CrossRef]
  22. Winkens, T.; Seifert, P.; Hollenbach, C.; Kühnel, C.; Gühne, F.; Freesmeyer, M. The FUSION iENA Study: Comparison of I-124-PET/US Fusion Imaging with Conventional Diagnostics for the Functional Assessment of Thyroid Nodules by Multiple Observers. Nuklearmedizin 2019, 58, 434–442. [Google Scholar] [CrossRef] [PubMed]
  23. Freesmeyer, M.; Winkens, T.; Weissenrieder, L.; Kühnel, C.; Gühne, F.; Schenke, S.; Drescher, R.; Seifert, P. Fusion iENA Scholar Study: Sensor-Navigated I-124-PET/US Fusion Imaging versus Conventional Diagnostics for Retrospective Functional Assessment of Thyroid Nodules by Medical Students. Sensors 2020, 20, 3409. [Google Scholar] [CrossRef]
  24. Brunn, J.; Block, U.; Ruf, G.; Bos, I.; Kunze, W.P.; Scriba, P.C. Volumetric analysis of thyroid lobes by real-time ultrasound (author’s transl). Dtsch. Med. Wochenschr 1981, 106, 1338–1340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Nygaard, B.; Nygaard, T.; Court-Payen, M.; Jensen, L.I.; Soe-Jensen, P.; Gerhard Nielsen, K.; Fugl, M.; Hegedus, L. Thyroid volume measured by ultrasonography and CT. Acta Radiol. 2002, 43, 269–274. [Google Scholar] [CrossRef] [PubMed]
  26. Shu, J.; Zhao, J.; Guo, D.; Luo, Y.; Zhong, W.; Xie, W. Accuracy and reliability of thyroid volumetry using spiral CT and thyroid volume in a healthy, non-iodine-deficient Chinese adult population. Eur. J. Radiol. 2011, 77, 274–280. [Google Scholar] [CrossRef]
  27. Cheung, W.; Stevenson, G.N.; de Melo Tavares Ferreira, A.E.G.; Alphonse, J.; Welsh, A.W. Feasibility of image registration and fusion for evaluation of structure and perfusion of the entire second trimester placenta by three-dimensional power Doppler ultrasound. Placenta 2020, 94, 13–19. [Google Scholar] [CrossRef]
  28. Brekke, S.; Rabben, S.I.; Støylen, A.; Haugen, A.; Haugen, G.U.; Steen, E.N.; Torp, H. Volume stitching in three-dimensional echocardiography: Distortion analysis and extension to real time. Ultrasound Med. Biol. 2007, 33, 782–796. [Google Scholar] [CrossRef]
  29. Chen, Y.; Manzanera, S.; Mompeán, J.; Ruminski, D.; Grulkowski, I.; Artal, P. Increased crystalline lens coverage in optical coherence tomography with oblique scanning and volume stitching. Biomed. Opt. Express 2021, 12, 1529–1542. [Google Scholar] [CrossRef]
  30. Sun, H.; Yang, J.; Fan, R.; Xie, K.; Wang, C.; Ni, X. Stepwise local stitching ultrasound image algorithms based on adaptive iterative threshold Harris corner features. Medicine 2020, 99, e22189. [Google Scholar] [CrossRef]
  31. Westphal, J.G.; Winkens, T.; Kühnel, C.; Freesmeyer, M. Low-activity 124I-PET/low-dose CT versus 131I probe measurements in pretherapy assessment of radioiodine uptake in benign thyroid diseases. J. Clin. Endocrinol. Metab. 2014, 99, 2138–2145. [Google Scholar] [CrossRef] [Green Version]
  32. Reinartz, P.; Sabri, O.; Zimny, M.; Nowak, B.; Cremerius, U.; Setani, K.; Büll, U. Thyroid volume measurement in patients prior to radioiodine therapy: Comparison between three-dimensional magnetic resonance imaging and ultrasonography. Thyroid 2002, 12, 713–717. [Google Scholar] [CrossRef]
  33. Miccoli, P.; Minuto, M.N.; Orlandini, C.; Galleri, D.; Massi, M.; Berti, P. Ultrasonography estimated thyroid volume: A prospective study about its reliability. Thyroid 2006, 16, 37–39. [Google Scholar] [CrossRef] [PubMed]
  34. Hussy, E.; Voth, E.; Schicha, H. Sonographic determination of thyroid volume—Comparison with surgical data. Nuklearmedizin 2000, 39, 102–107. [Google Scholar] [CrossRef] [PubMed]
  35. Shabana, W.; Peeters, E.; De Maeseneer, M. Measuring thyroid gland volume: Should we change the correction factor? Am. J. Roentgenol. 2006, 186, 234–236. [Google Scholar] [CrossRef] [PubMed]
  36. Knudsen, N.; Bols, B.; Bülow, I.; Jørgensen, T.; Perrild, H.; Ovesen, L.; Laurberg, P. Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 1999, 9, 1069–1074. [Google Scholar] [CrossRef]
  37. Ying, M.; Yung, D.M.; Ho, K.K. Two-dimensional ultrasound measurement of thyroid gland volume: A new equation with higher correlation with 3-D ultrasound measurement. Ultrasound Med. Biol. 2008, 34, 56–63. [Google Scholar] [CrossRef]
  38. Schlögl, S.; Werner, E.; Lassmann, M.; Terekhova, J.; Muffert, S.; Seybold, S.; Reiners, C. The use of three-dimensional ultrasound for thyroid volumetry. Thyroid 2001, 11, 569–574. [Google Scholar] [CrossRef]
  39. Ng, E.; Chen, T.; Lam, R.; Sin, D.; Ying, M. Three-dimensional ultrasound measurement of thyroid volume in asymptomatic male Chinese. Ultrasound Med. Biol. 2004, 30, 1427–1433. [Google Scholar] [CrossRef]
  40. Ying, M.; Sin, M.-H. Comparison of extended field of view and dual image ultrasound techniques: Accuracy and reliability of distance measurements in phantom study. Ultrasound Med. Biol. 2005, 31, 79–83. [Google Scholar] [CrossRef]
  41. Rago, T.; Bencivelli, W.; Scutari, M.; Di Cosmo, C.; Rizzo, C.; Berti, P.; Miccoli, P.; Pinchera, A.; Vitti, P. The newly developed three-dimensional (3D) and two-dimensional (2D) thyroid ultrasound are strongly correlated, but 2D overestimates thyroid volume in the presence of nodules. J. Endocrinol. Investig. 2006, 29, 423–426. [Google Scholar] [CrossRef] [PubMed]
  42. Liu, P.-R.; Lu, L.; Zhang, J.-Y.; Huo, T.-T.; Liu, S.-X.; Ye, Z.-W. Application of Artificial Intelligence in Medicine: An Overview. Curr. Med. Sci. 2021, 41, 1105–1115. [Google Scholar] [CrossRef] [PubMed]
  43. Castiglioni, I.; Rundo, L.; Codari, M.; Di Leo, G.; Salvatore, C.; Interlenghi, M.; Gallivanone, F.; Cozzi, A.; D’Amico, N.C.; Sardanelli, F. AI applications to medical images: From machine learning to deep learning. Phys. Med. 2021, 83, 9–24. [Google Scholar] [CrossRef] [PubMed]
  44. Feldkamp, A. Neue Entwicklungen im Ultraschall. Pädiatrie 2020, 32, 28–31. [Google Scholar] [CrossRef]
  45. Kollorz, E.N.K.; Hahn, D.A.; Linke, R.; Goecke, T.W.; Hornegger, J.; Kuwert, T. Quantification of thyroid volume using 3-D ultrasound imaging. IEEE Trans. Med. Imaging 2008, 27, 457–466. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Chang, C.-Y.; Lei, Y.-F.; Tseng, C.-H.; Shih, S.-R. Thyroid segmentation and volume estimation in ultrasound images. IEEE Trans. Biomed. Eng. 2010, 57, 1348–1357. [Google Scholar] [CrossRef]
  47. Trimboli, P.; Ruggieri, M.; Fumarola, A.; D’Alò, M.; Straniero, A.; Maiuolo, A.; Ulisse, S.; D’Armiento, M. A mathematical formula to estimate in vivo thyroid volume from two-dimensional ultrasonography. Thyroid 2008, 18, 879–882. [Google Scholar] [CrossRef]
  48. Malago, R.; D’Onofrio, M.; Ferdeghini, M.; Mantovani, W.; Colato, C.; Brazzarola, P.; Motton, M.; Mucelli, R.P. Thyroid volumetric quantification: Comparative evaluation between conventional and volumetric ultrasonography. J. Ultrasound Med. 2008, 27, 1727–1733. [Google Scholar] [CrossRef]
  49. Poudel, P.; Illanes, A.; Sheet, D.; Friebe, M. Evaluation of Commonly Used Algorithms for Thyroid Ultrasound Images Segmentation and Improvement Using Machine Learning Approaches. J. Healthc. Eng. 2018, 2018, 8087624. [Google Scholar] [CrossRef]
Biomedicines 11 00381 g001 550
Figure 1. 3DsnUS: probe movement ((A), black arrow) within the magnetic field generated by a transmitter ((A), red arrow); position sensors ((A), blue arrows) enable reconstruction of 3DsnUS images based on the probe movement and according to the position of the associated 2D frames ((A,B), black, blue, and red boxes). (C) shows a 3DsnUS data set of a right thyroid lobe displayed in the PMOD software in three dimensions: transverse ((C), a, red box), sagittal ((C), b, white box), coronal ((C), c yellow box).
Figure 1. 3DsnUS: probe movement ((A), black arrow) within the magnetic field generated by a transmitter ((A), red arrow); position sensors ((A), blue arrows) enable reconstruction of 3DsnUS images based on the probe movement and according to the position of the associated 2D frames ((A,B), black, blue, and red boxes). (C) shows a 3DsnUS data set of a right thyroid lobe displayed in the PMOD software in three dimensions: transverse ((C), a, red box), sagittal ((C), b, white box), coronal ((C), c yellow box).
Biomedicines 11 00381 g001
Biomedicines 11 00381 g002 550
Figure 2. 3DmsUS: constant fixation of the probe orthograde to the neck surface ((A), right angle); movement of the automated mechanically swept acoustic element inside the probe ((A), black arrow), acquired image sector ((A), red box), and reconstructed 3DmsUS data set on the US device (B). (C) shows a 3DsnUS data set of a right thyroid lobe displayed in the PMOD software in three dimensions: transverse ((C), a, red box), sagittal ((C), b, white box), coronal ((C), c yellow box).
Figure 2. 3DmsUS: constant fixation of the probe orthograde to the neck surface ((A), right angle); movement of the automated mechanically swept acoustic element inside the probe ((A), black arrow), acquired image sector ((A), red box), and reconstructed 3DmsUS data set on the US device (B). (C) shows a 3DsnUS data set of a right thyroid lobe displayed in the PMOD software in three dimensions: transverse ((C), a, red box), sagittal ((C), b, white box), coronal ((C), c yellow box).
Biomedicines 11 00381 g002
Biomedicines 11 00381 g003 550
Figure 3. Stitched 3DsnUS data sets superimposed to I-124-PET images. Examples of necessary alignment corrections (red and green arrows) on transversal ((A1): shifts on x- and y-axes; (A2): rotation on z-axis), coronal ((B1): shifts on x- and z-axes; (B2): rotation on y-axis), and sagittal plane ((C1): shift on z- and y-axes; (C2): rotation on x-axis). Corrected final results are shown in (A3,B3,C3).
Figure 3. Stitched 3DsnUS data sets superimposed to I-124-PET images. Examples of necessary alignment corrections (red and green arrows) on transversal ((A1): shifts on x- and y-axes; (A2): rotation on z-axis), coronal ((B1): shifts on x- and z-axes; (B2): rotation on y-axis), and sagittal plane ((C1): shift on z- and y-axes; (C2): rotation on x-axis). Corrected final results are shown in (A3,B3,C3).
Biomedicines 11 00381 g003
Biomedicines 11 00381 g004 550
Figure 4. Ellipsoid model (EM) exemplarily demonstrated on a right thyroid lobe on conUS images in transverse (A) and sagittal (B) planes as well as on CT images in transverse (C) and coronal (D) planes; diameters: vd = ventral-dorsal, ml = medial-lateral, cc = cranial-caudal.
Figure 4. Ellipsoid model (EM) exemplarily demonstrated on a right thyroid lobe on conUS images in transverse (A) and sagittal (B) planes as well as on CT images in transverse (C) and coronal (D) planes; diameters: vd = ventral-dorsal, ml = medial-lateral, cc = cranial-caudal.
Biomedicines 11 00381 g004
Biomedicines 11 00381 g005 550
Figure 5. Multiple manually drawn segmental contouring applications (MC) exemplarily demonstrated on a stitched 3DsnUS data set in PMOD software; manually outlined thyroid gland (blue lines) in transverse plane without (A) and with isthmus (B); representation of all drawn contours on coronal view (C). MC method applied on CT (D) and I-124-PET/CT (E) scans in Syngo.via software; manually outlined thyroid gland on a representative transverse plane.
Figure 5. Multiple manually drawn segmental contouring applications (MC) exemplarily demonstrated on a stitched 3DsnUS data set in PMOD software; manually outlined thyroid gland (blue lines) in transverse plane without (A) and with isthmus (B); representation of all drawn contours on coronal view (C). MC method applied on CT (D) and I-124-PET/CT (E) scans in Syngo.via software; manually outlined thyroid gland on a representative transverse plane.
Biomedicines 11 00381 g005
Biomedicines 11 00381 g006 550
Figure 6. Two different patient examples with isthmus nodules: stitched 3D-US data sets (3DsnUS: (A1,B1); 3DmsUS: (A3,B3)) as well as I-124-PET/3D-US image fusion for review of correct anatomical stitching (PET/3DsnUS: (A2,B2); PET/3DmsUS: (A4,B4)).
Figure 6. Two different patient examples with isthmus nodules: stitched 3D-US data sets (3DsnUS: (A1,B1); 3DmsUS: (A3,B3)) as well as I-124-PET/3D-US image fusion for review of correct anatomical stitching (PET/3DsnUS: (A2,B2); PET/3DmsUS: (A4,B4)).
Biomedicines 11 00381 g006
Biomedicines 11 00381 ch001 550
Chart 1. Correlation between volume measurements of conUS-EM versus PET/CT-MC (A), 3DsnUS-MC versus PET/CT-MC (B), and 3DmsUS-MC versus PET/CT-MC (C).
Chart 1. Correlation between volume measurements of conUS-EM versus PET/CT-MC (A), 3DsnUS-MC versus PET/CT-MC (B), and 3DmsUS-MC versus PET/CT-MC (C).
Biomedicines 11 00381 ch001
Biomedicines 11 00381 ch002 550
Chart 2. Bland–Altman plots of conUS-EM (A), 3DsnUS-MC (B), and 3DmsUS-MC (C) versus PET/CT-MC, respectively. The middle horizontal lines (bold) represent the mean, the outer lines (thinner) represent the LoA.
Chart 2. Bland–Altman plots of conUS-EM (A), 3DsnUS-MC (B), and 3DmsUS-MC (C) versus PET/CT-MC, respectively. The middle horizontal lines (bold) represent the mean, the outer lines (thinner) represent the LoA.
Biomedicines 11 00381 ch002
Biomedicines 11 00381 g007 550
Figure 7. Examples of suboptimal 3D-US images: incompletely captured thyroid pols on 3DmsUS in coronal plane ((A,B), red arrows); incompletely displayed thyroid tissue due to dorsal acoustic deletions behind calcifications ((C), red arrow) and a large nodule ((D), red arrow) in transverse plane; incompletely displayed isthmus ((E,F), white arrows) and artefacts due to too-fast moved US probe while 3D scan acquisition ((E,F), red arrows).
Figure 7. Examples of suboptimal 3D-US images: incompletely captured thyroid pols on 3DmsUS in coronal plane ((A,B), red arrows); incompletely displayed thyroid tissue due to dorsal acoustic deletions behind calcifications ((C), red arrow) and a large nodule ((D), red arrow) in transverse plane; incompletely displayed isthmus ((E,F), white arrows) and artefacts due to too-fast moved US probe while 3D scan acquisition ((E,F), red arrows).
Biomedicines 11 00381 g007
Biomedicines 11 00381 g008 550
Figure 8. Probe tilted laterally above the larynx (A1) and medially below the larynx (A2); tilt shown in the 3DsnUS data set of the right thyroid lobe (B); tilt laterally (C1) and medially (C2) in the corresponding single transverse slices of the 3DsnUS scan.
Figure 8. Probe tilted laterally above the larynx (A1) and medially below the larynx (A2); tilt shown in the 3DsnUS data set of the right thyroid lobe (B); tilt laterally (C1) and medially (C2) in the corresponding single transverse slices of the 3DsnUS scan.
Biomedicines 11 00381 g008
Biomedicines 11 00381 ch003 550
Chart 3. Complete workflow of 3D-US stitching with time specifications of the single working steps.
Chart 3. Complete workflow of 3D-US stitching with time specifications of the single working steps.
Biomedicines 11 00381 ch003
Biomedicines 11 00381 g009 550
Figure 9. Stitched 3DsnUS data set of a thyroid gland (A); secondary 99m-technetium-pertechnetate-SPECT/US image fusion (B); secondary I-124-PET/US image fusion (C).
Figure 9. Stitched 3DsnUS data set of a thyroid gland (A); secondary 99m-technetium-pertechnetate-SPECT/US image fusion (B); secondary I-124-PET/US image fusion (C).
Biomedicines 11 00381 g009
Table
Table 1. 3D-US parameter settings.
Table 1. 3D-US parameter settings.
Parameters3DsnUS3DmsUS
ProbeML6-15 (linear matrix array)RAB4-8 (convex 3D motor array)
contrast harmonic imaging (CHI)onon
CrossBeam functionmaxmax
VirtualConvex Modeonnot available
used frequencies10–15 MHz (individually optimized)6–8 MHz (individually optimized)
depth; mean (min-max)5 cm (3–7 cm)5.5 cm (5–8 cm)
number of foci; mean (min-max)3 (1–3)not adjustable
gain value; mean (min-max)47 (38–67)62 (58–90)
transmitting power100%100%
dynamic range69 dB69 dB
angle not applicable84° (max)
image qualitynot applicablemax
Abbreviations not yet introduced: MHz—Megahertz; min—minimum; max—maximum.
Table
Table 2. Results of the volume measurements.
Table 2. Results of the volume measurements.
MethodNrMeanSDMedianRange
(Min–Max)		LoA (Min)LoA (Max)
conUS-EM310.892, p < 0.000133.622.527.86.0–106.2−10.577.7
3DsnUS-MC310.988, p < 0.000140.324.635.76.8–124.7−7.988.5
3DmsUS-MC210.978, p < 0.000141.223.635.86.0–96.5−5.187.5
CT-EM310.956, p < 0.000141.927.035.36.0–121.6−11.094.8
CT-MC310.986, p < 0.000144.524.941.27.3–126.5−4.393.3
PET/CT-MC31reference44.125.839.57.8–129.7−6.394.9
Abbreviations not yet introduced: SD—standard deviation; LoA—limits of agreement.
Table
Table 3. Review of the literature containing thyroid 3D-US.
Table 3. Review of the literature containing thyroid 3D-US.
AuthorsObjects3D-USStitchingMethodReference
Standard		Results
PhantomsPatientssnmsEMMC
Schlögl et al., 2001 [38]XXX - Xphantoms,
post-mortem		D(%): 2.4 ± 8% (phantoms)
D(%): −3.6 ± 9.7% (post-mortem)
Vm: 29.1 mL
Ng et al., 2004 [39]XXX - Xphantomsr = 0.991–0.998 (p < 0.001)
Lyshchik et al., 2004 [15] XX - XPost-surgeryD(%): 1.8 ± 5.2%; Vm: 7 mL
Ying et al., 2005 [40] XX - X2D-
Rago et al., 2006 [41] XX - X3D-US-
Schlögl et al., 2006 [12]X X - XphantomsD(%): 0.6 ± 1.7%
Andermann et al., 2007 [13] XX - X3D-US-
Ying et al., 2008 [37] XX - X3D-US-
Freesmeyer et al., 2014 [16]X XX-XXphantomsD(%) 3DsnMC: −0.9 ± 5.2–0.9 ± 3.2%
D(%) 3DmsMC: 0.7 ± 4.6–2.8 ± 3.4%
volumes: 10–200 mL
Licht et al., 2014 [14] X X-XXCTD(%) MC: −1.1 ± 5.2%; Vm: 57.1 mL
Freesmeyer et al., 2018, Seifert et al., 2019 [19,20]X XXXXXphantomsD(%) 3DsnMC: −2.8 ± 2.4–1.4 ± 3.1%
D(%) 3DmsMC: 1.1 ± 3.6–3.2 ± 2.2%
volumes: 50–400 mL
present study XXXX XI-124-PET/CTD(%) 3DsnMC: −3.7 ± 3.7
D(%) 3DmsMC: 0.6 ± 4.8
Vm: 44.1 mL
Abbreviations not yet introduced: D(%)—relative differences to the reference standard; Vm—mean volume.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Seifert, P.; Ullrich, S.-L.; Kühnel, C.; Gühne, F.; Drescher, R.; Winkens, T.; Freesmeyer, M. Optimization of Thyroid Volume Determination by Stitched 3D-Ultrasound Data Sets in Patients with Structural Thyroid Disease. Biomedicines 2023, 11, 381. https://doi.org/10.3390/biomedicines11020381

AMA Style

Seifert P, Ullrich S-L, Kühnel C, Gühne F, Drescher R, Winkens T, Freesmeyer M. Optimization of Thyroid Volume Determination by Stitched 3D-Ultrasound Data Sets in Patients with Structural Thyroid Disease. Biomedicines. 2023; 11(2):381. https://doi.org/10.3390/biomedicines11020381

Chicago/Turabian Style

Seifert, Philipp, Sophie-Luise Ullrich, Christian Kühnel, Falk Gühne, Robert Drescher, Thomas Winkens, and Martin Freesmeyer. 2023. "Optimization of Thyroid Volume Determination by Stitched 3D-Ultrasound Data Sets in Patients with Structural Thyroid Disease" Biomedicines 11, no. 2: 381. https://doi.org/10.3390/biomedicines11020381

APA Style

Seifert, P., Ullrich, S. -L., Kühnel, C., Gühne, F., Drescher, R., Winkens, T., & Freesmeyer, M. (2023). Optimization of Thyroid Volume Determination by Stitched 3D-Ultrasound Data Sets in Patients with Structural Thyroid Disease. Biomedicines, 11(2), 381. https://doi.org/10.3390/biomedicines11020381

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop